Distribution of High-risk Human Papillomavirus Genotypes in Cervical Smear Samples and Evaluation of ASC-US, LSIL, and HSIL Results

宫颈涂片样本中高危型人乳头瘤病毒基因型的分布及ASC-US、LSIL和HSIL结果的评估

阅读:1

Abstract

CONTEXT: High-risk human papillomavirus (hrHPV) is the most common viral pathogen responsible for cervical cancers. Determining the rates of HPV positivity, genotypic distribution, and obtaining regional epidemiological data can provide guidance for preventive strategies. AIMS: This study aims to assess HPV positivity rates, age distribution, genotyping in abnormal cytologies, and then obtain regional epidemiological data. SETTINGS AND DESIGN: Descriptive study. MATERIALS AND METHODS: This study included 3510 women aged ≥18, whose cervical smear samples were examined at the Microbiology Laboratory. HPV detection and genotyping in cervical smear samples were performed using the polymerase chain reaction (PCR) method. Pap smears were evaluated according to the Bethesda system. STATISTICAL ANALYSIS USED: SPSS 23 (IBM Corp.) software was utilized for the statistical analysis of the data. RESULTS: The positivity rate for hrHPV infection was 10%. The most common genotype was other hrHPV. The rate of multiple hrHPV positive infections was 13.6%. The highest hrHPV positivity was observed in the age group ranging from 18 to 24 age group (28.7%). HPV infections were higher in abnormal cytologies (P < 0.001), with the highest positivity in LSIL (P < 0.001). The risk of having LSIL and HSIL cytology in HPV-positive individuals was 32.59 times higher than that in HPV-negative individuals (OR = 32.59; 95% CI 16.42-64.66). CONCLUSIONS: The hrHPV positivity was 10%, with other hrHPV strain infections being the most detected, followed by HPV 16. Due to the high detection of other hrHPV strain positivity in patients with abnormal cytology, conducting regional studies determining each hrHPV type separately, monitoring the natural course of infection with types other than HPV 16 and HPV 18, and benefiting vaccine studies are considered essential.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。